39
Views
22
CrossRef citations to date
0
Altmetric
CASE REPORT

Treatment of Vancomycin-intermediate Staphylcoccus aureus Endocarditis with Linezolid

, , , , &
Pages 483-486 | Received 22 Apr 2004, Accepted 11 May 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

David J Herrmann, William J Peppard, Nathan A Ledeboer, Melissa L Theesfeld, John A Weigelt & Bryan J Buechel. (2008) Linezolid for the treatment of drug-resistant infections. Expert Review of Anti-infective Therapy 6:6, pages 825-848.
Read now
Paola Mancino, Claudio Ucciferri, Katia Falasca, Eligio Pizzigallo & Jacopo Vecchiet. (2008) Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid. Scandinavian Journal of Infectious Diseases 40:1, pages 67-73.
Read now
Philippe Corne, Hélène Marchandin, Jean-Christophe MacIa & Olivier Jonquet. (2005) Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid. Scandinavian Journal of Infectious Diseases 37:11-12, pages 946-949.
Read now

Articles from other publishers (19)

C. G. K. Amiyangoda, H. Wimalaratna & S. Bowatte. (2017) A complicated prosthetic valve endocarditis due to methicillin resistant Staphylococci treated with linezolid and ciprofloxacin: a case report. BMC Research Notes 10:1.
Crossref
Donald C. Vinh & John M. Embil. 2016. Endocarditis. Endocarditis 181 280 .
Diane M. Gomes, Kristina E. Ward & Kerry L. LaPlante. (2015) Clinical Implications of Vancomycin Heteroresistant and Intermediately Susceptible Staphylococcus aureus . Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:4, pages 424-432.
Crossref
Karolina Akinosoglou, Efstratios Apostolakis, Markos Marangos & Geoffrey Pasvol. (2013) Native valve right sided infective endocarditis. European Journal of Internal Medicine 24:6, pages 510-519.
Crossref
Benjamin P. Howden, John K. Davies, Paul D. R. Johnson, Timothy P. Stinear & M. Lindsay Grayson. (2010) Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications . Clinical Microbiology Reviews 23:1, pages 99-139.
Crossref
E. Caro Martínez, S. Reus Bañuls, C. López Rodríguez & C. Escorín Pérez. (2009) Papel del linezolid en el tratamiento de endocarditis. Revista Clínica Española 209:4, pages 207-208.
Crossref
Chia-Yu Chi, Tsai-Ling Lauderdale, Shih-Min Wang, Jing-Ming Wu, Yu-Jen Yang & Ching-Chuan Liu. (2008) Health Care-Associated Endocarditis Caused by Staphylococcus aureus with Reduced Susceptibility to Vancomycin . Journal of Clinical Microbiology 46:2, pages 810-813.
Crossref
David Isaacs, Elizabeth Elliott, Ruth Gilbert, Virginia Moyer & Michael Pichichero. 2007. Evidence‐based Pediatric Infectious Diseases. Evidence‐based Pediatric Infectious Diseases 14 28 .
John L. Brusch. 2007. Infective Endocarditis: Management in the Era of Intravascular Devices. Infective Endocarditis: Management in the Era of Intravascular Devices 183 202 .
P. Muñoz, M. Rodríguez-Creixéms, M. Moreno, M. Marín, V. Ramallo, E. Bouza & GAME Study Group. (2007) Linezolid therapy for infective endocarditis. Clinical Microbiology and Infection 13:2, pages 211-215.
Crossref
Marci Drees & Helen Boucher. (2006) New agents for Staphylococcus aureus endocarditis. Current Opinion in Infectious Diseases 19:6, pages 544-550.
Crossref
E. E. Hill, P. Herijgers, M.-C. Herregods & W. E. Peetermans. (2006) Infective endocarditis treated with linezolid: case report and literature review. European Journal of Clinical Microbiology & Infectious Diseases 25:3, pages 202-204.
Crossref
P.C. Appelbaum. (2006) MRSA—the tip of the iceberg. Clinical Microbiology and Infection 12, pages 3-10.
Crossref
E.E. Hill, P. Herijgers, M-C. Herregods & W.E. Peetermans. (2006) Evolving trends in infective endocarditis. Clinical Microbiology and Infection 12:1, pages 5-12.
Crossref
Dennis L. Stevens. (2006) The Role of Vancomycin in the Treatment Paradigm. Clinical Infectious Diseases 42:Supplement_1, pages S51-S57.
Crossref
Donald C. Vinh & John M. Embil. 2006. Endocarditis. Endocarditis 121 183 .
M. Souli, K. Pontikis, Z. Chryssouli, I. Galani & H. Giamarellou. (2005) Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid. European Journal of Clinical Microbiology & Infectious Diseases 24:11, pages 760-762.
Crossref
John D. Perry. (2005) Endocarditis guidelines: authors' response. Journal of Antimicrobial Chemotherapy 56:2, pages 432-433.
Crossref
Parvathy Pillai, James S. Tan, Joseph R. DiPersio & Joseph P. Myers. (2005) Streptococcus sanguinis Endocarditis in a Patient Who Received Clindamycin for Dental Prophylaxis. Infectious Diseases in Clinical Practice 13:2, pages 73-77.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.